Smith Hunter C's Form 4 filing
Rhythm Pharmaceuticals, Inc. (RYTM) · filed Feb 12, 2026
- Accession no.
- 0001104659-26-014546
- Filed
- Feb 12, 2026
- Trade date
- Feb 10-12, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 10 non-derivative transactions and 2 derivative transactions. Open-market sales total $708.6K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Smith Hunter CCIK 0001636385 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 10, 2026 | Common Stock | SSaleDisposed | −1,913 | $102.66 | −$196,388.58 | 123,624 | Direct | |
| Feb 10, 2026 | Common Stock | SSaleDisposed | −700 | $103.68 | −$72,576 | 122,924 | Direct | |
| Feb 10, 2026 | Common Stock | SSaleDisposed | −100 | $104.76 | −$10,476 | 122,824 | Direct | |
| Feb 11, 2026 | Common Stock | SSaleDisposed | −2,266 | $98.37 | −$222,906.42 | 120,558 | Direct | |
| Feb 11, 2026 | Common Stock | SSaleDisposed | −400 | $99.44 | −$39,776 | 120,158 | Direct | |
| Feb 11, 2026 | Common Stock | SSaleDisposed | −100 | $100.85 | −$10,085 | 120,058 | Direct | |
| Feb 12, 2026 | Common Stock | SSaleDisposed | −292 | $96.26 | −$28,107.92 | 119,766 | Direct | |
| Feb 12, 2026 | Common Stock | SSaleDisposed | −400 | $97.67 | −$39,068 | 119,366 | Direct | |
| Feb 12, 2026 | Common Stock | SSaleDisposed | −800 | $98.99 | −$79,192 | 118,566 | Direct | |
| Feb 12, 2026 | Common Stock | SSaleDisposed | −100 | $100.10 | −$10,010 | 118,466 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 11, 2026 | Common Stock | AGrant or awardAcquired | +25,000 | $0.00 | $0 | 25,000 | Direct | |
| Feb 11, 2026 | Common Stock | AGrant or awardAcquired | +37,500 | $0.00 | $0 | 37,500 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.